These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Ghana: the experience in the land highly endemic for Buruli ulcer]. Yotsu R Nihon Hansenbyo Gakkai Zasshi; 2012 Apr; 81(1-2):155-9. PubMed ID: 22586949 [No Abstract] [Full Text] [Related]
23. Outcome of Streptomycin-Rifampicin treatment of Buruli Ulcer in two Ghanaian districts. Iddrisah FN; Yeboah-Manu D; Nortey PA; Nyarko KM; Anim J; Antara SN; Kenu E; Wurapa F; Afari EA Pan Afr Med J; 2016; 25(Suppl 1):13. PubMed ID: 28149438 [TBL] [Abstract][Full Text] [Related]
29. Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans. Zingue D; Bouam A; Tian RBD; Drancourt M Clin Microbiol Rev; 2018 Jan; 31(1):. PubMed ID: 29237707 [TBL] [Abstract][Full Text] [Related]
30. To Buruli or not to Buruli. Ho L; Cohn J; Comte E Trop Doct; 2013 Apr; 43(2):92. PubMed ID: 23796682 [No Abstract] [Full Text] [Related]
31. Outcome of patients with buruli ulcer after surgical treatment with or without antimycobacterial treatment in Ghana. Schunk M; Thompson W; Klutse E; Nitschke J; Opare-Asamoah K; Thompson R; Fleischmann E; Siegmund V; Herbinger KH; Adjei O; Fleischer B; Loscher T; Bretzel G Am J Trop Med Hyg; 2009 Jul; 81(1):75-81. PubMed ID: 19556570 [TBL] [Abstract][Full Text] [Related]
32. Persistence of Mycobacterium ulcerans disease (Buruli Ulcer) in the historical focus of Kasongo Territory, the Democratic Republic of Congo. Suykerbuyk P; Wambacq J; Phanzu DM; Haruna H; Nakazawa Y; Ooms K; Kamango K; Stragier P; Singa JN; Ekwanzala F; De Herdt E; De Maeyer P; Kestens L; Portaels F Am J Trop Med Hyg; 2009 Nov; 81(5):888-94. PubMed ID: 19861627 [TBL] [Abstract][Full Text] [Related]
33. Buruli ulcer in West Africa: strategies for early detection and treatment in the antibiotic era. Webb BJ; Hauck FR; Houp E; Portaels F East Afr J Public Health; 2009 Aug; 6(2):144-7. PubMed ID: 20000019 [TBL] [Abstract][Full Text] [Related]
34. Orally administered combined regimens for treatment of Mycobacterium ulcerans infection in mice. Ji B; Chauffour A; Robert J; Lefrançois S; Jarlier V Antimicrob Agents Chemother; 2007 Oct; 51(10):3737-9. PubMed ID: 17664316 [TBL] [Abstract][Full Text] [Related]
35. Impacts of dosing frequency of the combination rifampin-streptomycin on its bactericidal and sterilizing activities against Mycobacterium ulcerans in mice. Ji B; Chauffour A; Aubry A; Robert J; Ibrahim M; Jarlier V Antimicrob Agents Chemother; 2009 Jul; 53(7):2955-9. PubMed ID: 19364857 [TBL] [Abstract][Full Text] [Related]
36. Challenges Associated with Management of Buruli Ulcer/Human Immunodeficiency Virus Coinfection in a Treatment Center in Ghana: A Case Series Study. Tuffour J; Owusu-Mireku E; Ruf MT; Aboagye S; Kpeli G; Akuoku V; Pereko J; Paintsil A; Bonney K; Ampofo W; Pluschke G; Yeboah-Manu D Am J Trop Med Hyg; 2015 Aug; 93(2):216-23. PubMed ID: 26055745 [TBL] [Abstract][Full Text] [Related]
37. Short report: edematous Mycobacterium ulcerans infection (Buruli ulcer) on the face: a case report. Phanzu DM; Ablordey A; Imposo DB; Lefevre L; Mahema RL; Suykerbuyk P; Meyers WM; Portaels F Am J Trop Med Hyg; 2007 Dec; 77(6):1099-102. PubMed ID: 18165530 [TBL] [Abstract][Full Text] [Related]
38. Clinical outcomes of Ghanaian Buruli ulcer patients who defaulted from antimicrobial therapy. Klis S; Kingma RA; Tuah W; van der Werf TS; Stienstra Y Trop Med Int Health; 2016 Sep; 21(9):1191-6. PubMed ID: 27456068 [TBL] [Abstract][Full Text] [Related]
39. Buruli ulcer (Mycobacterium ulcerans infection). Walsh DS; Portaels F; Meyers WM Trans R Soc Trop Med Hyg; 2008 Oct; 102(10):969-78. PubMed ID: 18657836 [TBL] [Abstract][Full Text] [Related]
40. Buruli ulcer accompanied by pain in a Japanese patient. Onoe H; Yotsu RR; Nakanaga K; Hoshino Y; Ishii N; Takeuchi T J Dermatol; 2012 Oct; 39(10):869-70. PubMed ID: 22168180 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]